Last reviewed · How we verify

NCT04462575

Reconstruction of Atrophic Maxillary Ridges Using Mandibular Blocks With and Without Coverage Using Collagen Membrane

Completed NA Last updated 11 July 2024
What this trial tests

NA trial testing Onlay bone block covered using collagen membrane in Bone Augmentation in 30 participants. Completed in 30 September 2023.

Timeline
15 April 2021
Primary endpoint
30 September 2023
30 September 2023

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date15 April 2021
Primary completion30 September 2023
Estimated completion30 September 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 46, any sex, with Bone Augmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Is the use of collagen membrane on top of particulate bone mixture covered by onlay bone block in Maxilla better than the use of mixture of particulate bone covered by onlay bone block without the use of collagen membrane, in terms of bone quality and bone quantity?

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Horizontal Maxillary Ridge Augmentation Using Autogenous Bone Blocks With and Without Collagen Membranes: A Randomized Controlled Trial.
    Ismail M, Shawky M, Fattouh H, Mounir M, et al · · 2026 · PMID 41184218 · DOI 10.1111/clr.70059

Verify or expand the search:

Other recruiting trials for Bone Augmentation

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04462575.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing